CONCLUSION
There are a range of alternative inhalers available that people
currently using Vectura products could switch to if it this becomes
necessary because of a tobacco industry takeeover. A consideration based
on beneficence, non-maleficence, autonomy, and distributive justice
demonstrates strong ethical reasons to support this switch, which can be
achieved without any significant risk to patient outcomes.